Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2607
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorHeaney, R-
dc.contributor.authorChesnut, C-
dc.contributor.authorCros, M-
dc.contributor.authorBOS, Kim-
dc.date.accessioned2007-11-15T13:41:27Z-
dc.date.available2007-11-15T13:41:27Z-
dc.date.issued2002-
dc.identifier.citationOSTEOPOROSIS INTERNATIONAL, 13. p. S37-S37-
dc.identifier.issn0937-941X-
dc.identifier.urihttp://hdl.handle.net/1942/2607-
dc.language.isoen-
dc.publisherSPRINGER-VERLAG LONDON LTD-
dc.titleRisedronate reduces the risk of first vertebral fracture in osteoporotic women as soon as 1 year.-
dc.typeJournal Contribution-
dc.identifier.epageS37-
dc.identifier.spageS37-
dc.identifier.volume13-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notesLimburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp Maastricht, Maastricht, Netherlands. Creighton Univ, Omaha, NE 68178 USA. Univ Washington, Seattle, WA 98195 USA. Procter & Gamble Pharmaceut, Geneva, Switzerland. Procter & Gamble Pharmaceut, Cincinnati, OH USA.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000179698100095-
item.fulltextNo Fulltext-
item.fullcitationGEUSENS, Piet; Heaney, R; Chesnut, C; Cros, M & BOS, Kim (2002) Risedronate reduces the risk of first vertebral fracture in osteoporotic women as soon as 1 year.. In: OSTEOPOROSIS INTERNATIONAL, 13. p. S37-S37.-
item.contributorGEUSENS, Piet-
item.contributorHeaney, R-
item.contributorChesnut, C-
item.contributorCros, M-
item.contributorBOS, Kim-
item.accessRightsClosed Access-
crisitem.journal.issn0937-941X-
crisitem.journal.eissn1433-2965-
Appears in Collections:Research publications
Show simple item record

Page view(s)

8
checked on Jul 28, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.